Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maen Obeidat (Vancouver, Canada). Molecular variations underlying the heterogeneity in lung function in COPD. International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes

Member's Comments

No comment yet.

Related content which might interest you: Genetic variations and lung function Source: Eur Respir J 2006; 28: Suppl. 50, 525s Year: 2006 Genetic influences on lung function decline in AATD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Genetic determinants of lung function in COPD: A genome-wide association study Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010 A possible role of Krüppel-like factor 5 in small airway wall fibrosis in COPD Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 The lung parenchyma in COPD patients: in vitro mechanics and its correlation with inflammatory and structural changes Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 A potential role for extracellular matrix proteins in lung ageing in COPD Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Consensus network analysis reveals pathways associated with lung function decline in both COPD and IPF Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 Lung function measurements versus structural lung disease in CF Source: Breathe 2008; 5: 65 Year: 2008 New approaches to the understanding of complex chronic lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=345 Year: 2006 Physiological phenotypes of COPD: the role of resting lung volumes Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020 Molecular phenotyping of chronic bronchitis: mucin and inflammatory gene expression heterogeneity in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Emphysema distribution determines distinct pulmonary function features Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006 The influence of hyperinflation on body composition and cytokine profile in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013